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Human papillomavirus (HPV) is a virus from the 
Papillomaviridae family of non-enveloped double-
stranded DNA viruses. Sixteen HPV genera have been 
identified according to a classification scheme based 
on biological and genetic properties. Of these, only 
three are found in humans: alpha-papillomavirus, beta-
papillomavirus, and gamma-papillomavirus. Viruses 
belonging to the alpha-papillomavirus group infect 
mucosal surfaces and are found in the cervix. This genus 
contains 15 species (1–15), of which species 7 and 9 
contain the genotypes HPV-18 and HPV-16, respectively. 
In particular, genotypes of species 9 are associated with 
the development of malignant lesions (1).
Some HPV strains can infect the stratified squamous 
epithelium in the cervical mucosa. Approximately 40 
HPV genotypes have been identified, of which 15 are 
considered high-risk and 25 are considered low-risk. 
In particular, HPV-16 and HPV-18 are associated with 
cervical neoplasia, making the HPV the third leading 
cause of cancer related deaths worldwide (2,3). 
Squamous intraepithelial lesions (SILs) are precursors 
of uterine cervical cancer (CC). According to the current 
Bethesda classification, cervical lesions are classified as 
low-grade SILs (LSILs) and high-grade SILs (HSILs) 
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(4). The reported prevalence of HSILs in Mexico is 
18.8%, and 51.92% of patients with these lesions had 
HPV infection (5).
The aim of this study was to determine the HPV 
genotypes in SILs in a population in Mexico using the 
Linear Array® HPV Genotyping test (Roche, Mannheim, 
Germany). This cross-sectional study was approved 
by the local Research Ethics Committee. One hundred 
twenty-nine patients who met the inclusion criteria 
agreed to participate in the study by signing an informed 
consent letter.
Samples from female patients diagnosed with SILs by 
colposcopy were obtained during a visit to a dysplasia 
clinic at the 221st Mexican Social Security Institute of 
the Maternal and Perinatal Hospital “Monica Pretelini” 
at Mexican Health Institute, and the Center for Research 
in Medical Sciences of the Autonomous University 
of Mexico. Cervical samples without SILs diagnosed 
by colposcopy were obtained from women who were 
patients at the gynecology service centers. The samples 
were collected by cervical scraping and were preserved 
in ThinPrep® PreservCyt® Solution (Hologic Inc., 
Marlborough, MA, USA).
Patients completed a questionnaire to provide 
information on their age, area of residence, education 
level, numbers of sexual partners, participation in anal 
sex, age at first intercourse, smoking, use of hormonal 
contraception, use of condoms, number of pregnancies, 
and number of vaginal deliveries. 
For HPV genotyping, DNA was extracted from 129 
cervical swab samples using the Amplicor kit (Roche) 
and the gene for β-globin, along with HPV, were 
simultaneously isolated. Specimens that tested positive 
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for HPV were subsequently genotyped using the 
aforementioned Linear Array HPV Genotyping assay. 
The test amplifies target DNA using the polymerase 
chain reaction and uses nucleic acid hybridization to 
detect 37 anogenital HPV DNA genotypes (6, 11, 16, 
18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 
56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73 
(MM9), 81, 82 (MM4), 83 (MM7), 84 (MM8), IS39, 
and CP6108) and includes a β-globin probe to check for 
sample integrity and to reduce the risk of false negatives. 
Thirteen genotypes have been defined as HPV types 
with a high-risk of carcinogenesis (16, 18, 31, 33, 35, 
39, 45, 51, 52, 56, 58, 59, and 68).
For statistical analysis, chi-square testing for SILs 
were calculated using SSPS 17.0 software (SPSS Inc., 
Chicago, IL, USA). Frequencies and percentages were 
used for the presence of genotypes.
One hundred and twenty-nine cervical samples were 
obtained (one from each patient). Patient characteristics 
are shown in Table 1. Ninety-nine samples were 












30 years or less   34 (26.4) 27 (27.3)   7 (23.3) 0.432
Older than 30   95 (73.6) 72 (72.7) 23 (76.7)
Occupation
Housewife   66 (51.2) 57 (57.6)   9 (30) 0.007
Work away from home   63 (48.8) 42 (42.4) 21 (70)
Level of education
Less than high school   66 (51.2) 59 (59.6%)   7 (23.3) 0.000
From high school onward   63 (48.8) 40 (40.4%) 23 (76.7)
Sexual partners
0–1   68 (52.7) 53 (53.5) 15 (50) 0.447
2 or more   61 (47.3) 46 (46.5) 15 (50)
Anal sex
Yes   27 (20.9) 26 (26.3)   1 (3.3) 0.004
No 102 (79.1) 73 (73.7) 29 (96.7)
Age at first intercourse
Under 16 years   21 (16.3%) 20 (20.2)   1 (3.3) 0.020
16 or more 108 (83.7%) 79 (78.8) 29 (96.7)
Smoking
Yes   26 (22.5%) 21 (21.2)   5 (16.7) 0.399
No 103 (77.5%) 78 (78.8) 25 (83.3)
Hormonal contraceptive use
Yes   21 (16.3) 15 (15.2)   6 (20) 0.352
No 108 (83.7) 84 (84.8) 24 (80)
Condom use
Yes   28 (20.2) 20 (20.2)   8 (26.7) 0.399
No 101 (79.8) 79 (79.8) 22 (73.3)
Pregnancies
Nulliparous   18 (14) 15 (15.2)   3 (10) 0.353
With pregnancy 111 (86) 84 (84.8) 27 (90)
Vaginal births
Have had less than 3 partos vaginales   49 (38) 40 (40.4)   9 (30) 0.209
Have had 3 or more vaginal deliveries   80 (62) 59 (59.6) 21(70)
Age of first pregnancy
Under 16 years   70 (54.3) 58 (56.6) 12 (40) 0.57
16 or more   59 (45.7) 41 (41.4) 18 (60)
f (%), frequency (percentage); value of p, Chi-square.
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HPV in SIL
obtained from women with SILs and 30 were obtained 
from women without SILs.
The 129 samples were genotyped for HPV and 49 
(38%) were positive for HPV (Table 2). The 24 HPV 
genotypes found in these samples included 11 high-
risk genotypes and 13 low-risk genotypes. Notably, four 
women without SILs were infected with HPV. Three of 
these women were infected with high-risk genotypes 
(HPV-16, HPV-33, and HPV-39) and one with a low-
risk genotype (HPV-71). The most prevalent high-risk 
genotype in both patients with infections with a single 
genotype and patients with infection with more than one 
genotype was HPV-16, followed by HPV-51 and HPV-
84.
In the patients with HPV-positive samples, 15 patients 
(30.6%) were infected with multiple genotypes and 13 
were infected with high-risk genotypes (86.6%). The 
more frequent combination was of a high-risk genotype 
with a low-risk genotype, which was found in six cases 
(40%). A maximum of eight genotypes was obtained in 
a single sample (four high-risk and four low-risk). The 
presence of more genotypes was observed in patients 
with HSILs (Table 3).
Genotypes 26, 35, 42, 55, 64, 68, 69, 70, 72, 73, 










n % n % n % n %
High-risk 
16 19 15   1 3.3  5 7.7 13 38
18  1 0.8   0    0  1 1.5   0    0
31  4 3.1   0    0  3 4.6   1 2.9
33  1 0.8   1 3.3  0    0   0    0
39  4 3.1   1 3.3  1 1.5   2 2.9
45  2 1.6   0   0  2 3.1   0    0
51  5 3.9   0   0  3 4.6   2 5.9
52  4 3.1   0   0  2 3.1   1 2.9
56  2 1.6   0   0  2 3.1   0    0
58  3 2.3   0   0  1 1.5   2 5.9
59  3 2.3   0   0  1 1.5   2 5.9
Low-risk
6  3 2.3   0   0  1 1.5   2 5.9
11  1 0.8   0   0  0    0   1 2.9
53  4 3.1   0   0  2 3.1   2 5.9
54  1 0.8   0   0  1 1.5   0    0
61  2 1.6   0   0  1 1.5   1 2.9
62  2 1.6   0   0  2 3.1   0    0
66  1 0.8   0   0  1 1.5   0    0
67  2 1.6   0   0  1 1.5   1 2.9
71  2 1.6   1 3.3  1 1.5   0    0
81  1 0.8   0   0  0    0   1 2.9
83  2 1.6   0   0  2 3.1   0    0
84  5 3.9   0   0  3 4.6   2 5.9
CP6108  1 0.8   0   0  1 1.5   0    0
Overall patients 49 38   4 13.3 20 31 25 74
Table 3.  Infection multiple genotypes regarding high risk and 
intraepithelial lesion type
Multiple infection Risk SIL
54, 66,84 3 LR LSIL
62, CP6108 2 LR LSIL
31, 84 HR, LR LSIL
51, 53 HR , LR LSIL
16 ,83 HR , LR LSIL
18 ,84 HR , LR LSIL 
16, 52 2 HR LSIL
 6, 39 HR ,  LR LSIL
51, 59 2 HR LSIL
56,81,84 HR , 2 LR HSIL 
16, 52,  53 2 HR , LR HSIL
11, 16, 59 2 HR , LR HSIL
39, 67 HR , LR HSIL
6,16,51,53,56,59,61,84 4 HR , 4 LR HSIL
16,31 2 HR HSIL
HR, high risk; LR, low risk; LSIL, low-grade squamous intraepithelial 
lesion; HSIL, high-grade squamous intraepithelial lesion.
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82, and 1S39 were not identified in the patients. The 
samples from the 129 patients were analyzed for the 
presence of HPV; 38% were positive, and the most 
prevalent genotype was HPV-16. These findings are 
consistent with other studies on SILs from Tunisia, 
China, Gambia, Turkey, and Japan (6–10). 
Presently, 30.6% of the patients were positive for 
multiple infections, which is consistent with another 
study on SILs, which reported a value of 29.6% (10). 
We identified more high-risk genotypes than low-risk 
genotypes, most often HPV-16 (33.3%) combined with 
HPV-52 and HPV-53. In Japan, HPV-16 and HPV-52 
have been reported most often (9.9%); the same study 
had identified one patient with five genotypes (10), 
and interestingly, we detected one patient with eight 
genotypes. A study in Benin reported that HPV-59 was 
the genotype most frequently identified in multiple 
infections in LSILs (26.32%) (11). The present findings 
confirm that the sampled Mexican population had 
infections caused by high-risk genotypes, which may 
influence the development of CC in these individuals. 
These data highlight the importance of studies that 
determine the genotypes infecting the Mexican 
population, and the importance of a proper vaccination 
system.
The population studied here may be at risk of 
developing CC, as it has been suggested that HPV-16 
and HPV-18 are major risk factors for the development 
of CC and SILs (12).
In conclusion, in the population studied, the most 
frequent genotype was HPV-16, multiple infections were 
found, and four patients without injury tested positive 
for the HPV.
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